Kalaris Therapeutics Inc (KLRS) vs PDS Biotechnology Corporation (PDSB)
A side-by-side comparison of Kalaris Therapeutics Inc and PDS Biotechnology Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KLRS
Kalaris Therapeutics Inc
$2.90HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
PDSB
PDS Biotechnology Corporation
$1.08HealthcareDelayed quote: Oct 6, 2026, 11:35 AM EDT
Total return — KLRS vs PDSB
growth of $100 · dividends reinvested · last 10yKLRS -99.1% (-37.3%/yr)PDSB -99.5% (-40.6%/yr)KLRS compounded faster over this window
KLRS PDSB
KLRS vs PDSB: by the numbers
- •KLRS is the larger company ($63M vs $60M market cap).
Metrics side by side
Valuation
| Metric | KLRS | PDSB |
|---|---|---|
| P/B ratio | 1.10 | N/A |
Profitability
| Metric | KLRS | PDSB |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -76.75% | N/A |
| ROIC | -52.40% | -3699.99% |
Growth (annualized)
| Metric | KLRS | PDSB |
|---|---|---|
| Total return CAGR (5Y) | -81.13% | -39.13% |
Frequently asked
- How have KLRS and PDSB total returns compared?
- Over the past 5 years, KLRS delivered -81.13% and PDSB delivered -39.13% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.